share_log

12月31日A股投资避雷针︱维康药业:及实控人刘忠良因涉嫌信息披露违法违规 被证监会立案

On December 31, A-share investment warning: Zhejiang Wecome Pharmaceutical and its actual controller Liu Zhongliang are being investigated by the China Securities Regulatory Commission for suspected violations of information disclosure laws.

Gelonghui Finance ·  Dec 30, 2024 09:02

Guo Yongfang, a shareholder of China Investment Technology, plans to reduce his shareholding by no more than 1%; Xiao Jinming, a shareholder of YingTong Telecommunication, intends to decrease his shareholding by no more than 2.47%; Mingchun Technology, a shareholder of Jingsheng Co., plans to reduce its stake by no more than 2%; Anyuan Coal Industry Group has not yet obtained the "Free Transfer Agreement" signed with Jiangneng Group and Jiangte Holdings; Zhongbai Holdings Group has not yet received the specific implementation plan from Wuhan Business Alliance; Zhejiang Wecome Pharmaceutical and its actual controller Liu Zhongliang are under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure regulations.

big
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment